# Chaga Mushroom Sayan Variant (Inonotus obliquus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chaga-mushroom-sayan-variant
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Inonotus obliquus, Siberian Chaga, Sayan Chaga, Birch Conk, Black Mass, Sterile Conk Trunk Rot, Clinker Polypore, Chaga Sclerotium, King of Herbs, Diamond of the Forest, Czaga, Tschaga, Pakuri

## Overview

Chaga mushroom (Inonotus obliquus), particularly the Sayan variant harvested from Siberian birch forests, contains betulinic acid, inotodiol, and polysaccharide beta-glucans as primary bioactives. These compounds exert antitumor, [antioxidant](/ingredients/condition/antioxidant), and [immunomodulatory](/ingredients/condition/immune-support) effects via apoptosis induction, [NF-κB](/ingredients/condition/inflammation) pathway suppression, and Toll-like receptor activation.

## Health Benefits

• Anticancer properties: In vitro studies show growth inhibition of human cancer cells (breast, prostate) with IC50 ≤10 µM for key triterpenoids; mouse studies demonstrated 33.7% tumor weight reduction (preliminary evidence) • Anti-allergic effects: Mouse studies showed inhibition of anaphylactic shock and reduced IgE levels with shift to Th1 immune response (preliminary evidence) • Antimutagenic activity: In vitro Ames test demonstrated 77-80% inhibition of MNNG-induced mutagenesis at 50 μg/plate (preliminary evidence) • [Oxidative stress](/ingredients/condition/antioxidant) protection: In vitro studies on lymphocytes showed protection against oxidative DNA damage (preliminary evidence) • [Immune modulation](/ingredients/condition/immune-support): Animal studies indicate increased Th1 IFN-γ production from spleen cells (preliminary evidence)

## Mechanism of Action

Betulinic acid and inotodiol in Chaga inhibit NF-κB signaling and downregulate Bcl-2 anti-apoptotic proteins, promoting caspase-3-mediated apoptosis in malignant cells. [Beta-glucan](/ingredients/condition/immune-support)s bind Dectin-1 and TLR-2 receptors on macrophages and dendritic cells, triggering [pro-inflammatory cytokine](/ingredients/condition/inflammation) release (TNF-α, IL-6) that enhances adaptive immunity. Ergosterol peroxide and triterpenoids also inhibit COX-2 enzyme activity, contributing to the observed anti-inflammatory and anti-allergic effects.

## Clinical Summary

Most Chaga research consists of in vitro and rodent studies rather than human clinical trials. In vitro studies demonstrated IC50 values ≤10 µM for key triterpenoids against human breast and prostate cancer cell lines, indicating potent growth inhibition under controlled conditions. Mouse model studies reported a 33.7% reduction in tumor weight and inhibition of anaphylactic shock responses, suggesting [immunomodulatory](/ingredients/condition/immune-support) activity. Human evidence remains limited to small observational reports, and no large-scale randomized controlled trials have confirmed these effects in people, so findings should be interpreted cautiously.

## Nutritional Profile

Chaga Mushroom Sayan Variant (Inonotus obliquus) from the Sayan mountain region of Siberia is characterized by elevated concentrations of bioactive compounds compared to standard Chaga, attributed to harsh environmental stressors and host tree (Betula pendula/Betula pubescens) characteristics. Key compositional data: BIOACTIVE COMPOUNDS: Betulinic acid (0.5–2.0 mg/g dry weight), Betulin (1.0–3.5 mg/g dry weight, higher in Sayan variant due to birch bark resin incorporation), Inotodiol (triterpenoid, ~0.3–1.2 mg/g dry weight), Ergosterol (provitamin D2 precursor, ~0.1–0.8 mg/g dry weight), Lanosterol (~0.2–0.6 mg/g dry weight), Lupeol (~0.1–0.4 mg/g dry weight). POLYSACCHARIDES: [Beta-glucan](/ingredients/condition/immune-support)s (primarily β-1,3 and β-1,6 linkages, 2–8% of dry weight); total polysaccharide content 15–35% dry weight. Melanin-polyphenol complex (sclerotial pigment): 12–25% dry weight — among the highest ORAC values of any mushroom (~52,000–146,700 µmol TE/100g, source-dependent). Superoxide dismutase (SOD) activity: 35,000–55,000 IU/g dry weight (bioactivity, not nutrient per se). MINERALS: Potassium (~500–900 mg/100g dry weight), Manganese (~3–9 mg/100g dry weight, notably high), Zinc (~2–5 mg/100g dry weight), Iron (~5–12 mg/100g dry weight), Magnesium (~80–150 mg/100g dry weight), Calcium (~30–80 mg/100g dry weight), Copper (~0.5–1.5 mg/100g dry weight), Rubidium and Cesium present in trace amounts specific to Sayan geological substrate. VITAMINS: Vitamin B2 (Riboflavin, ~0.4–1.0 mg/100g dry weight), Vitamin B3 (Niacin, ~3–7 mg/100g dry weight), Vitamin D2 (ergocalciferol, formed from ergosterol upon UV exposure, variable: 10–400 IU/100g dry weight depending on sun exposure pre-harvest), Pantothenic acid (~0.5–1.5 mg/100g dry weight). MACRONUTRIENTS (per 100g dry weight): Crude protein: 2–8% (predominantly non-digestible sclerotial proteins and lectins; bioavailability low without extraction, estimated <30% from raw powder); Carbohydrates: 55–70% (majority as structural polysaccharides and melanin complexes, low glycemic impact); Dietary fiber: 30–50%; Fat: <2% (predominantly sterols and triterpene lipids); Calories: ~250–310 kcal/100g dry weight. BIOAVAILABILITY NOTES: Hot water extraction (decoction at 70–90°C, 30–60 min) significantly increases polysaccharide and mineral bioavailability (est. 60–80% extraction efficiency for beta-glucans); alcohol/ethanol extraction (40–70%) preferentially extracts triterpenoids (betulinic acid, inotodiol) with ~70–85% extraction efficiency. Dual extraction (water + ethanol) is recommended for full-spectrum bioavailability. Raw powder consumption yields substantially lower bioavailability for most bioactives due to chitin cell wall barrier. Sayan variant specifically noted for ~15–20% higher betulin and betulinic acid content versus generalized I. obliquus sourcing, likely due to host birch species and altitude (800–2000m elevation stress). Oxalic acid content (~100–300 mg/100g) may modestly reduce mineral absorption; individuals with kidney stones should exercise caution.

## Dosage & Preparation

No clinically studied human dosages are available. Preclinical studies used: in vitro anticancer assays with triterpenoids at IC50 ≤10 µM; mouse antitumor dosing of 0.2 mg/day of specific triterpenoid for 20 days; antimutagenic effects at 50 μg/plate. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Chaga is generally well-tolerated at typical supplemental doses (1–3 g/day dried extract), but its high oxalate content poses a risk of kidney stone formation with prolonged high-dose use, as documented in at least one case report of oxalate nephropathy. It has known antiplatelet and anticoagulant properties, making concurrent use with warfarin, heparin, or aspirin potentially hazardous due to additive bleeding risk. Chaga may also potentiate hypoglycemic effects of insulin or oral diabetes medications by lowering [blood glucose](/ingredients/condition/weight-management), requiring monitoring. Safety during pregnancy and breastfeeding has not been established, and use should be avoided in these populations.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found in the research dossier; evidence is limited to preclinical in vitro and animal studies. Key studies include in vitro cytotoxicity assays on human cancer cell lines (PMID: 38268969), a mouse tumor study showing 33.7% reduction with triterpenoid treatment (PMID: 38046279), and anti-allergic effects in mice (PMID: 23535020).

## Historical & Cultural Context

Inonotus obliquus (Chaga) has been used in folk medicine of Siberia, Russia, North America, Northern Europe, China, and Korea for centuries, primarily as a tea or extract for general health, cancer, [inflammation](/ingredients/condition/inflammation), and infections. Siberian traditions particularly emphasize its use from birch-hosted sclerotia in regions like the Sayan mountains.

## Synergistic Combinations

Microalgae extracts, Reishi mushroom, Turkey tail, Vitamin D3, Elderberry

## Frequently Asked Questions

### What makes the Sayan variant of Chaga different from regular Chaga?

The Sayan variant is harvested from the Sayan mountain region of Siberia, where extreme cold and specific birch species (Betula pendula) produce sclerotia with reportedly higher concentrations of betulinic acid and inotodiol compared to Chaga sourced from other regions. These environmental stressors are thought to upregulate secondary metabolite production, though direct head-to-head comparative analyses between regional variants remain limited in the published literature.

### What is the effective dosage of Chaga mushroom supplement?

Traditional use and preliminary research suggest 1–3 grams per day of dried Chaga powder or a standardized hot-water extract equivalent, with polysaccharide content typically standardized to 20–30% beta-glucans. Hot-water extraction is critical because betulinic acid and beta-glucans require high temperatures to become bioavailable, making raw powder less effective than properly processed extracts. No human clinical trials have formally established an optimal therapeutic dose.

### Can Chaga mushroom really fight cancer?

In vitro studies show Chaga triterpenoids, particularly inotodiol and betulinic acid, inhibit human breast and prostate cancer cell lines with IC50 values at or below 10 µM, and mouse studies reported a 33.7% reduction in tumor weight. However, these findings have not been replicated in human clinical trials, and no regulatory body has approved Chaga as a cancer treatment. It should not replace conventional oncology care.

### Does Chaga mushroom interact with blood thinners?

Yes, Chaga contains compounds that inhibit platelet aggregation and may enhance anticoagulant activity, creating a clinically significant interaction with drugs such as warfarin, clopidogrel, and heparin. Concurrent use can increase bleeding risk, and patients on anticoagulation therapy should consult a physician before using Chaga supplements. Preoperative discontinuation at least two weeks prior to surgery is a common precautionary recommendation.

### Is Chaga mushroom safe for daily long-term use?

Long-term daily use raises concern primarily due to Chaga's unusually high oxalate content, which has been linked to at least one confirmed case of oxalate nephropathy (kidney damage) in a patient consuming large amounts daily for several months. For individuals with a history of kidney stones or impaired renal function, daily use is inadvisable. Healthy adults using moderate doses (1–2 g/day) for shorter durations appear to tolerate it well, but long-term human safety data are lacking.

### What research quality supports Chaga mushroom's anticancer claims?

Current evidence for Chaga's anticancer properties comes primarily from in vitro studies showing growth inhibition of breast and prostate cancer cells at concentrations ≤10 µM, and preliminary mouse studies demonstrating 33.7% tumor weight reduction. While these findings are promising, human clinical trials are limited, meaning results cannot yet be definitively applied to cancer treatment in people. More rigorous clinical research is needed before Chaga can be recommended as a primary or adjunctive cancer therapy.

### Who should avoid Chaga mushroom supplementation?

Individuals taking anticoagulant or antiplatelet medications should consult a healthcare provider before using Chaga, as it may potentiate blood-thinning effects. People with autoimmune conditions should exercise caution, as Chaga's immune-modulating properties could theoretically affect disease progression. Pregnant and nursing women should avoid supplementation due to insufficient safety data in these populations.

### How does the Sayan variant's bioavailability compare to other Chaga extract forms?

The Sayan variant's bioavailability depends heavily on the extraction method used (hot water, dual extraction, or standardized triterpenoid extracts), rather than the geographic origin alone. Dual-extraction methods and standardized extracts typically offer superior bioavailability of active compounds like betulin and inotodiol compared to simple hot-water infusions. Individual absorption also varies based on gut health, stomach pH, and whether Chaga is consumed with food or on an empty stomach.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*